209 related articles for article (PubMed ID: 24036547)
21. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice.
Liu X; Karnell JL; Yin B; Zhang R; Zhang J; Li P; Choi Y; Maltzman JS; Pear WS; Bassing CH; Turka LA
J Clin Invest; 2010 Jul; 120(7):2497-507. PubMed ID: 20516645
[TBL] [Abstract][Full Text] [Related]
22. Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching.
Wang JH; Alt FW; Gostissa M; Datta A; Murphy M; Alimzhanov MB; Coakley KM; Rajewsky K; Manis JP; Yan CT
J Exp Med; 2008 Dec; 205(13):3079-90. PubMed ID: 19064702
[TBL] [Abstract][Full Text] [Related]
23. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
24. Abnormal thymic development, impaired immune function and gamma delta T cell lymphomas in a TL transgenic mouse strain.
Obata Y; Taguchi O; Matsudaira Y; Hasegawa H; Hamasima N; Takahashi T
J Exp Med; 1991 Aug; 174(2):351-62. PubMed ID: 1713249
[TBL] [Abstract][Full Text] [Related]
25. NPM-ALK transgenic mice spontaneously develop T-cell lymphomas and plasma cell tumors.
Chiarle R; Gong JZ; Guasparri I; Pesci A; Cai J; Liu J; Simmons WJ; Dhall G; Howes J; Piva R; Inghirami G
Blood; 2003 Mar; 101(5):1919-27. PubMed ID: 12424201
[TBL] [Abstract][Full Text] [Related]
26. Thymic lymphomas are resistant to Nur77-mediated apoptosis.
Matuszyk J; Kobzdej M; Ziolo E; Kalas W; Kisielow P; Strzadala L
Biochem Biophys Res Commun; 1998 Aug; 249(1):279-82. PubMed ID: 9705872
[TBL] [Abstract][Full Text] [Related]
27. Myeloid, B and T lymphoid and mixed lineage thymic lymphomas in the irradiated mouse.
Boulton E; Cleary H; Plumb M
Carcinogenesis; 2002 Jun; 23(6):1079-85. PubMed ID: 12082032
[TBL] [Abstract][Full Text] [Related]
28. T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus.
Hagenbeek TJ; Spits H
Leukemia; 2008 Mar; 22(3):608-19. PubMed ID: 18046443
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of Ras, Raf and L-myc but not Bcl-2 family proteins is linked with resistance to TCR-mediated apoptosis and tumorigenesis in thymic lymphomas from TCR transgenic mice.
Kobzdej M; Matuszyk J; Strzadala L
Leuk Res; 2000 Jan; 24(1):33-8. PubMed ID: 10634643
[TBL] [Abstract][Full Text] [Related]
30. Clonal deletion of thymocytes as a tumor escape mechanism.
Lauritzsen GF; Hofgaard PO; Schenck K; Bogen B
Int J Cancer; 1998 Oct; 78(2):216-22. PubMed ID: 9754655
[TBL] [Abstract][Full Text] [Related]
31. ATM-deficient thymic lymphoma is associated with aberrant tcrd rearrangement and gene amplification.
Zha S; Bassing CH; Sanda T; Brush JW; Patel H; Goff PH; Murphy MM; Tepsuporn S; Gatti RA; Look AT; Alt FW
J Exp Med; 2010 Jul; 207(7):1369-80. PubMed ID: 20566716
[TBL] [Abstract][Full Text] [Related]
32. Cell of origin in radiation-induced premalignant thymocytes with differentiation capability in mice conditionally losing one Bcl11b allele.
Go R; Hirose S; Katsuragi Y; Obata M; Abe M; Mishima Y; Sakimura K; Kominami R
Cancer Sci; 2013 Aug; 104(8):1009-16. PubMed ID: 23663453
[TBL] [Abstract][Full Text] [Related]
33. Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.
Qing Y; Gerson SL
PLoS One; 2017; 12(8):e0182175. PubMed ID: 28767666
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical, molecular, and cytogenetic analysis of a consecutive series of 20 peripheral T-cell lymphomas and lymphomas of uncertain lineage, including 12 Ki-1 positive lymphomas.
Ebrahim SA; Ladanyi M; Desai SB; Offit K; Jhanwar SC; Filippa DA; Lieberman PH; Chaganti RS
Genes Chromosomes Cancer; 1990 May; 2(1):27-35. PubMed ID: 2177640
[TBL] [Abstract][Full Text] [Related]
35. Role of thymic selection in the development of thymic lymphomas in TCR transgenic mice.
Strzadala L; Miazek A; Matuszyk J; Kisielow P
Int Immunol; 1997 Jan; 9(1):127-38. PubMed ID: 9043954
[TBL] [Abstract][Full Text] [Related]
36. 53BP1 and p53 synergize to suppress genomic instability and lymphomagenesis.
Morales JC; Franco S; Murphy MM; Bassing CH; Mills KD; Adams MM; Walsh NC; Manis JP; Rassidakis GZ; Alt FW; Carpenter PB
Proc Natl Acad Sci U S A; 2006 Feb; 103(9):3310-5. PubMed ID: 16492765
[TBL] [Abstract][Full Text] [Related]
37. Fidelity and infidelity in commitment to B-lymphocyte lineage development.
Rolink AG; Schaniel C; Busslinger M; Nutt SL; Melchers F
Immunol Rev; 2000 Jun; 175():104-11. PubMed ID: 10933595
[TBL] [Abstract][Full Text] [Related]
38. Distinct oncogenic phenotypes in hematopoietic specific deletions of Trp53.
Palanichamy JK; Tran TM; King JK; Katzman S; Ritter AJ; Sharma G; Tso C; Contreras JR; Fernando TR; Sanford JR; Rao DS
Sci Rep; 2023 May; 13(1):7490. PubMed ID: 37160922
[TBL] [Abstract][Full Text] [Related]
39. Deregulated expression of RasGRP1 initiates thymic lymphomagenesis independently of T-cell receptors.
Klinger MB; Guilbault B; Goulding RE; Kay RJ
Oncogene; 2005 Apr; 24(16):2695-704. PubMed ID: 15829980
[TBL] [Abstract][Full Text] [Related]
40. Abnormal rearrangement within the alpha/delta T-cell receptor locus in lymphomas from Atm-deficient mice.
Liyanage M; Weaver Z; Barlow C; Coleman A; Pankratz DG; Anderson S; Wynshaw-Boris A; Ried T
Blood; 2000 Sep; 96(5):1940-6. PubMed ID: 10961898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
